Literature DB >> 1903309

Acute hematologic effects of interferon alpha, interferon gamma, tumor necrosis factor alpha and interleukin 2.

W E Aulitzky1, H Tilg, W Vogel, W Aulitzky, M Berger, G Gastl, M Herold, C Huber.   

Abstract

This study was designed to investigate acute effects of various doses of the cytokines IFN-alpha, IFN-gamma, Interleukin 2 and tumor necrosis factor alpha on white blood cell differential counts. Before initiation of phase II trials, a dose-determination phase was performed, where three different dose levels of each cytokine were applied as a single dose. White blood cell differential counts were assessed immediately before and 2, 12, 24, 48 and 168 h after injection. Patients enrolled suffered from metastatic cancer or chronic active hepatitis. In addition, IFN-alpha was administered to five healthy volunteers. Results indicate that cytokines cause rapid and transient changes in the numbers of leukocyte subsets. Hematologic changes were cell-type- and cytokine-specific: transient lymphopenia was observed after administration of all four cytokines, reaching a nadir 12 to 24 h after subcutaneous injection. Administration of TNF-alpha and IFN-gamma also caused transient monocytopenia. Neutrophilia developed after administration of Interleukin 2, IFN-alpha and TNF-alpha. We conclude that cytokines play a key role in the regulation of peripheral blood cell traffic by their capacity to influence homing patterns of peripheral blood leukocytes.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1903309     DOI: 10.1007/bf01714980

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  33 in total

1.  Tumour necrosis factor in hepatosplenic schistosomiasis.

Authors:  K Zwingenberger; E Irschick; J G Vergetti Siqueira; A R Correia Dacal; H Feldmeier
Journal:  Scand J Immunol       Date:  1990-02       Impact factor: 3.487

2.  Interleukin-2 enhances biopterins and catecholamines production during adoptive immunotherapy for various cancers.

Authors:  H Baker; S L Marcus; O Frank; D P Petrylak; B DeAngelis; J P Dutcher; P H Wiernik
Journal:  Cancer       Date:  1989-09-15       Impact factor: 6.860

3.  Immunologic study of human recombinant interleukin-2 (low-dose) in patients with advanced renal cell carcinoma.

Authors:  K Marumo; J Muraki; M Ueno; M Tachibana; N Deguchi; S Baba; S Jitsukawa; M Hata; H Tazaki
Journal:  Urology       Date:  1989-03       Impact factor: 2.649

4.  Interferon-gamma-increased adherence of lymphocytes to high endothelial venules.

Authors:  H R Hendriks; C Korn; R E Mebius; G Kraal
Journal:  Immunology       Date:  1989-10       Impact factor: 7.397

5.  Improvement of platelet counts in steroid-unresponsive idiopathic immune thrombocytopenic purpura after short-course therapy with recombinant alpha 2b interferon.

Authors:  S J Proctor; G Jackson; P Carey; A Stark; R Finney; P Saunders; G Summerfield; D Maharaj; A Youart
Journal:  Blood       Date:  1989-11-01       Impact factor: 22.113

6.  Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.

Authors:  G Gastl; M Werter; B De Pauw; C Nerl; W Aulitzky; I von Lüttichau; H Tilg; J Thaler; A Lang; K Abbrederis
Journal:  Leukemia       Date:  1989-06       Impact factor: 11.528

7.  Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor.

Authors:  J R Gamble; J M Harlan; S J Klebanoff; M A Vadas
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Stimulation of endothelial cell binding of lymphocytes by tumor necrosis factor.

Authors:  D Cavender; Y Saegusa; M Ziff
Journal:  J Immunol       Date:  1987-09-15       Impact factor: 5.422

9.  Immune mediators increase adherence of T-lymphocytes to human lung fibroblasts.

Authors:  F Hampson; M Monick; M W Peterson; G W Hunninghake
Journal:  Am J Physiol       Date:  1989-02

10.  Molecules mediating adhesion of T and B cells, monocytes and granulocytes to vascular endothelial cells.

Authors:  J Prieto; P G Beatty; E A Clark; M Patarroyo
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

View more
  9 in total

1.  Immunomodulatory oligonucleotides containing a cytosine-phosphate-2'-deoxy-7-deazaguanosine motif as potent toll-like receptor 9 agonists.

Authors:  Ekambar R Kandimalla; Lakshmi Bhagat; Yukui Li; Dong Yu; Daqing Wang; Yan-Ping Cong; Sam S Song; Jimmy X Tang; Tim Sullivan; Sudhir Agrawal
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-28       Impact factor: 11.205

Review 2.  Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation.

Authors:  Yi-chi M Kong; Wei-Zen Wei; Yaron Tomer
Journal:  Ann N Y Acad Sci       Date:  2010-01       Impact factor: 5.691

Review 3.  Interferon alpha treatment and thyroid dysfunction.

Authors:  Yaron Tomer; Jason T Blackard; Nagako Akeno
Journal:  Endocrinol Metab Clin North Am       Date:  2007-12       Impact factor: 4.741

4.  Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF alpha/IFN alpha therapy.

Authors:  M Nagel-Hiemke; C Hiemke; G Kummer; T Moritz; H Müller; S Seeber; N Niederle
Journal:  Ann Hematol       Date:  1992-09       Impact factor: 3.673

Review 5.  Clinical toxicity of interleukin-2.

Authors:  T Vial; J Descotes
Journal:  Drug Saf       Date:  1992 Nov-Dec       Impact factor: 5.606

6.  Can the peripheral blood monocyte count be used as a marker of CSF resistance to antiretroviral drugs?

Authors:  Bruce J Brew; Louise Pemberton; John Ray
Journal:  J Neurovirol       Date:  2004       Impact factor: 2.643

7.  Implications of prognostic variables in the assessment of autoimmunity in hepatitis C patients receiving interferon therapy.

Authors:  Mahwish Arooj; Arif Malik; Abdul Basit; Mahmood Husain Qazi; Muhammad Asif; Mohammad Sarwar Jamal; Maged Mostafa Mahmoud; Hani Choudhry; Peter Natesan Pushparaj; Mahmood Rasool
Journal:  Bioinformation       Date:  2016-06-15

8.  Acute phase responses induced in dwarf goats by r.BolL(-1beta), r.BolL(-2) and r.BolFN(-gamma).

Authors:  C T Duin; T Wensing; A S Miert
Journal:  Mediators Inflamm       Date:  1992       Impact factor: 4.711

9.  Influenza vaccination accelerates recovery of ferrets from lymphopenia.

Authors:  Nedzad Music; Adrian J Reber; Aleksandr S Lipatov; Ram P Kamal; Kristy Blanchfield; Jason R Wilson; Ruben O Donis; Jacqueline M Katz; Ian A York
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.